)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Establishment Labs
Establishment Labs (ESTA) investor relations material
Establishment Labs 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary14 Jan, 2026
Strategic Positioning and Innovation
Achieved FDA approval and launched in the U.S. in late 2024, marking the fastest launch in US breast aesthetics history and driving rapid market entry and growth.
Established global presence in over 90 countries, with 4.5 million devices and 218+ patents, and positioned as a leader in breast aesthetics and reconstruction.
Focused on science-based innovation, with patented technologies like SmoothSilk, TRUEMONOBLOC®, BLUSEAL®, and VISCOELASTIC PROGRESSIVE GEL® for superior safety and performance.
Motiva implants demonstrated less than 1% device-related complications over five years, with US IDE study data showing 0.5% capsular contracture, 0.6% rupture, and 8.8% reoperation.
Marketing initiatives, including celebrity endorsements and social media campaigns, generated over 9.2 billion impressions and led to 93% of patients requesting Motiva by name.
Financial Performance and Growth Outlook
Reported 27% global revenue growth in 2025, reaching $210.5–$211.5 million, with U.S. revenue exceeding $45 million in the first year.
Achieved positive adjusted EBITDA in Q3 and Q4 2025, with cash balance at $75.5 million by year-end and expectations for free cash flow positive in 2026.
Gross margin surpassed 70% in Q3 2025, with operating expenses growing slower than revenue and continued leverage expected.
At least 25% annual revenue growth expected in 2026 and 2027, with significant margin expansion as infrastructure is already established.
On track for meaningful earnings in 2027, driven by disciplined cost management and high-margin U.S. business.
U.S. Market Expansion and Drivers
Captured approximately 20% U.S. market share by end of 2025, with over 1,500 accounts and ongoing expansion.
Key growth drivers include new product launches (Preservé), increased marketing, and expanding the sales force by up to 15 reps in 2026.
Preservé, a minimally invasive platform, targets untapped segments and is expected to generate over $30 million in 2026, with 55% of patients willing to pay a premium.
Submitted PMA supplement for smaller sizes and reconstruction indication, aiming to double addressable U.S. market upon approval.
Minimal competitive response from larger players, enabling rapid share gains.
US market share growth: any competitive shifts
Preservé's market expansion potential in US
Recon indication: timeline and 2026 revenue
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Establishment Labs earnings date
Q4 202527 Feb, 2026
Establishment Labs
Next Establishment Labs earnings date
Q4 202527 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Establishment Labs Holdings Inc. (ESTA) is a medical technology company focused on the manufacture and marketing of medical devices for aesthetic and reconstructive plastic surgery. The company's flagship product line includes silicone gel-filled breast implants under the brand name Motiva Implants. These include Motiva Ergonomix and Motiva Ergonomix2, which are gravity sensitive round soft silicone-gel-filled breast implants, as well as the Motiva Flora Tissue Expander, a breast tissue expander. Establishment Labs sells its products through distributors and a direct sales force across regions including Europe, the Middle East, Latin America, and Asia. The company is headquartered in Alajuela, Costa Rica, and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage